Cardiac innervation and sudden cardiac death

Current Cardiology Reviews

Volumn 5, Issue 4, 2009, Pages 289-295

  Ieda, Masaki ^a   Fukuda, Keiichi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Arrhythmia; Cardiac nerve; Nerve growth factor; Sema3a; Silent myocardial ischemia; Sudden cardiac death

Indexed keywords

ADRENALIN; CALCITONIN GENE RELATED PEPTIDE ANTIBODY; CATECHOLAMINE; NERVE GROWTH FACTOR; PEPTIDE ANTIBODY; PROTEIN C FOS; RECOMBINANT NERVE GROWTH FACTOR; SEMAPHORIN 3A; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANATOMICAL VARIATION; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC CYSTOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DOWN REGULATION; DRUG EFFICACY; EMBRYO PATTERN FORMATION; GENE OVEREXPRESSION; GENE TRANSFER; HEART ARREST; HEART DEVELOPMENT; HEART DISEASE; HEART INFARCTION; HEART INNERVATION; HEART MUSCLE ISCHEMIA; HEART SENSORY NEUROPATHY; HEART VENTRICLE ARRHYTHMIA; HUMAN; NERVE REGENERATION; NERVE SPROUTING; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; SINUS BRADYCARDIA; SUDDEN DEATH; SYMPATHETIC NERVE; SYSTEMIC THERAPY; UPREGULATION;

EID: 70449567764     PISSN: 1573403X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340309789317904     Document Type: Review

References (72)

1. Cao JM, Chen LS, KenKnight BH, et al. Nerve sprouting and sudden cardiac death. Circ Res 2000; 86: 816-821 (Pubitemid 30217832)
2. Kaye DM, Vaddadi G, Gruskin SL, Du XJ, Esler MD. Reduced myocardial nerve growth factor expression in human and experimental heart failure. Circ Res 2000; 86: E80-4.
3. Cao JM, Fishbein MC, Han JB, et al. Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation 2000; 101: 1960-1969 (Pubitemid 30225278)
4. Chen LS, Zhou S, Fishbein MC, Chen PS. New perspectives on the role of autonomic nervous system in the genesis of arrhythmias. J Cardiovasc Electrophysiol 2007; 18: 123-127 (Pubitemid 44952760)
5. Chen PS, Chen LS, Cao JM, Sharifi B, Karagueuzian HS, Fishbein MC. Sympathetic nerve sprouting, electrical remodeling and the mechanisms of sudden cardiac death. Cardiovasc Res 2001; 50: 409-416 (Pubitemid 32382168)
6. Dae MW, Lee RJ, Ursell PC, Chin MC, Stillson CA, Moise NS. Heterogeneous sympathetic innervation in German shepherd dogs with inherited ventricular arrhythmia and sudden cardiac death. Circulation 1997; 96: 1337-1342
7. Qu J, Robinson RB. Cardiac ion channel expression and regulation: the role of innervation. J Mol Cell Cardiol 2004; 37: 439-448 (Pubitemid 38953372)
8. Hjalmarson A. Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period. Am J Cardiol 1997; 80: 35J-9J.
9. Poole-Wilson PA, Swedberg K, Cleland JG, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 2003; 362: 7-13. (Pubitemid 36835815)
10. Faerman I, Faccio E, Milei J, et al. Autonomic neuropathy and painless myocardial infarction in diabetic patients. Histologic evidence of their relationship. Diabetes 1977; 26: 1147-1158
11. Crowley C, Spencer SD, Nishimura MC, et al. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 1994; 76: 1001-1011 (Pubitemid 24106381)
12. Ito M, Zipes DP. Efferent sympathetic and vagal innervation of the canine right ventricle. Circulation 1994; 90: 1459-1468 (Pubitemid 24284467)
13. Crick SJ, Sheppard MN, Ho SY, Anderson RH. Localisation and quantitation of autonomic innervation in the porcine heart I: conduction system. J Anat 1999; 195: 341-357 (Pubitemid 29520624)
14. Crick SJ, Wharton J, Sheppard MN, et al. Innervation of the human cardiac conduction system. A quantitative immunohistochemical and histochemical study. Circulation 1994; 89: 1697-1708
15. Chow LT, Chow SS, Anderson RH, Gosling JA. Innervation of the human cardiac conduction system at birth. Br Heart J 1993; 69: 430-435 (Pubitemid 23171120)
16. Hansson M, Kjorell U, Forsgren S. Increased immunoexpression of atrial natriuretic peptide in the heart conduction system of the rat after cardiac sympathectomy. J Mol Cell Cardiol 1998; 30: 2047-2057 (Pubitemid 28495330)
17. Randall WC, Szentivanyi M, Pace JB, Wechsler JS, Kaye MP. Patterns of sympathetic nerve projections onto the canine heart. Circ Res 1968; 22: 315-323
18. Schultz HD, Ustinova EE. Capsaicin receptors mediate free radicalinduced activation of cardiac afferent endings. Cardiovasc Res 1998; 38: 348-355
19. Hua F, Harrison T, Qin C, et al. c-Fos expression in rat brain stem and spinal cord in response to activation of cardiac ischemiasensitive afferent neurons and electrostimulatory modulation. Am J Physiol Heart Circ Physiol 2004; 287: H2728-38.
20. Ieda M, Kanazawa H, Ieda Y, et al. Nerve growth factor is critical for cardiac sensory innervation and rescues neuropathy in diabetic hearts. Circulation 2006; 114: 2351-2363
21. Snider WD. Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 1994; 77: 627-638
22. Lockhart ST, Turrigiano GG, Birren SJ. Nerve growth factor modulates synaptic transmission between sympathetic neurons and cardiac myocytes. J Neurosci 1997; 17: 9573-9582
23. Brennan C, Rivas-Plata K, Landis SC. The p75 neurotrophin receptor influences NT-3 responsiveness of sympathetic neurons in vivo. Nat Neurosci 1999; 2: 699-705. (Pubitemid 30491190)
24. Heumann R, Korsching S, Scott J, Thoenen H. Relationship between levels of nerve growth factor (NGF) and its messenger RNA in sympathetic ganglia and peripheral target tissues. EMBO J 1984; 3: 3183-3189
25. Kanki H, Fukuda K, Okushi K, et al. Comparison of nerve growth factor mRNA expression in cardiac and skeletal muscle in streptozotocin-induced diabetic mice. Life Sci 1999; 65: 2305-2313
26. Zhou S, Chen LS, Miyauchi Y, et al. Mechanisms of cardiac nerve sprouting after myocardial infarction in dogs. Circ Res 2004; 95: 76-83. (Pubitemid 38931838)
27. Kimura K, Ieda M. Kanazawa H, et al. Cardiac sympathetic rejuvenation: a link between nerve function and cardiac hypertrophy. Circ Res 2007; 100: 1755-1764 (Pubitemid 46987868)
28. Kuo DC, Oravitz JJ, DeGroat WC. Tracing of afferent and efferent pathways in the left inferior cardiac nerve of the cat using retrograde and transganglionic transport of horseradish peroxidase. Brain Res 1984; 321: 111-118
29. Zahner MR, Li DP, Chen SR, Pan HL. Cardiac vanilloid receptor 1-expressing afferent nerves and their role in the cardiogenic sympathetic reflex in rats. J Physiol 2003; 551: 515-523
30. Bennett DL, Dmietrieva N, Priestley JV, Clary D, McMahon SB. trkA, CGRP and IB4 expression in retrogradely labelled cutaneous and visceral primary sensory neurones in the rat. Neurosci Lett 1996; 206: 33-36
31. Trupp M, Ryden M, Jornvall H, et al. Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J Cell Biol 1995; 130: 137-148
32. Kuruvilla R, Zweifel LS, Glebova NO, et al. A neurotrophin signaling cascade coordinates sympathetic neuron development through differential control of TrkA trafficking and retrograde signaling. Cell 2004; 118: 243-255 (Pubitemid 38962579)
33. Wang L, Wang DH. TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice. Circulation 2005; 112: 3617-3623 (Pubitemid 43739540)
34. Pan HL, Chen SR. Sensing tissue ischemia: another new function for capsaicin receptors? Circulation 2004; 110: 1826-1831
35. Park AM, Armin S, Azarbal A, Lai A, Chen PS, Fishbein MC. Distribution of cardiac nerves in patients with diabetes mellitus: an immunohistochemical postmortem study of human hearts. Cardiovasc Pathol 2002; 11: 326-331 (Pubitemid 35380021)
36. Schratzberger P, Walter DH, Rittig K, et al. Reversal of experimental diabetic neuropathy by VEGF gene transfer. J Clin Invest 2001; 107: 1083-1092 (Pubitemid 32422905)
37. Fernyhough P, Diemel LT, Hardy J, Brewster WJ, Mohiuddi L, Tomlinson DR. Human recombinant nerve growth factor replaces deficient neurotrophic support in the diabetic rat. Eur J Neurosci 1995; 7: 1107-1110
38. Christianson JA, Riekhof JT, Wright DE. Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice. Exp Neurol 2003; 179: 188-199
39. Unger JW, Klitzsch T, Pera S, Reiter R. Nerve growth factor (NGF) and diabetic neuropathy in the rat: morphological investigations of the sural nerve, dorsal root ganglion, and spinal cord. Exp Neurol 1998; 153: 23-34. (Pubitemid 28452294)
40. Bierhaus A, Haslbeck KM, Humpert PM, et al. Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J Clin Invest 2004; 114: 1741-1751 (Pubitemid 40385530)
41. Feldman EL, Russell JW, Sullivan KA, Golovoy D. New insights into the pathogenesis of diabetic neuropathy. Curr Opin Neurol 1999; 12: 553-563 (Pubitemid 30028615)
42. Emanueli C, Salis MB, Pinna A, Graiani G, Manni L, Madeddu P. Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs. Circulation 2002; 106: 2257-2262 (Pubitemid 35222222)
43. Hellweg R, Hartung HD. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy. J Neurosci Res 1990; 26: 258-267
44. Schmid H, Forman LA, Cao X, Sherman PS, Stevens MJ. Heterogeneous cardiac sympathetic denervation and decreased myocardial nerve growth factor in streptozotocin-induced diabetic rats: implications for cardiac sympathetic dysinnervation complicating diabetes. Diabetes 1999; 48: 603-608 (Pubitemid 29106876)
45. Hellweg R, Raivich G, Hartung HD, Hock C, Kreutzberg GW. Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy. Exp Neurol 1994; 130: 24-30.
46. Futamatsu H, Suzuki J, Mizuno S, et al. Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis: a potential role for induction of T helper 2 cytokines. Circ Res 2005; 96: 823-830 (Pubitemid 40604965)
47. Sakata K, Kumagai H, Osaka M, et al. Potentiated sympathetic nervous and renin-angiotensin systems reduce nonlinear correlation between sympathetic activity and blood pressure in conscious spontaneously hypertensive rats. Circulation 2002; 106: 620-625 (Pubitemid 34827714)
48. Apfel SC, Schwartz S, Adornato BT, et al. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group. JAMA 2000; 284: 2215-2221 (Pubitemid 30808112)
49. Goss JR, Goins WF, Lacomis D, Mata M, Glorioso JC, Fink DJ. Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse. Diabetes 2002; 51: 2227-2232 (Pubitemid 34729029)
50. Sasaki K, Chancellor MB, Goins WF, et al. Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathy. Diabetes 2004; 53: 2723-2730 (Pubitemid 39299286)
51. Zhan Y, Kim S, Izumi Y, et al. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression. Arterioscler Thromb Vasc Biol 2003; 23: 795-801. (Pubitemid 36566168)
52. Francis N, Farinas I, Brennan C, et al. NT-3, like NGF, is required for survival of sympathetic neurons, but not their precursors. Dev Biol 1999; 210: 411-427 (Pubitemid 29283013)
53. Hassankhani A, Steinhelper ME, Soonpaa MH, et al. Overexpression of NGF within the heart of transgenic mice causes hyperinnervation, cardiac enlargement, and hyperplasia of ectopic cells. Dev Biol 1995; 169: 309-321
54. Ieda M, Fukuda K, Hisaka Y, et al. Endothelin-1 regulates cardiac sympathetic innervation in the rodent heart by controlling nerve growth factor expression. J Clin Invest 2004; 113: 876-884
55. Ieda M, Kanazawa H, Kimura K, et al. Sema3a maintains normal heart rhythm through sympathetic innervation patterning. Nat Med 2007; 13: 604-612 (Pubitemid 46828481)
56. Puschel AW, Adams RH, Betz H. Murine semaphorin D/collapsin is a member of a diverse gene family and creates domains inhibitory for axonal extension. Neuron 1995; 14: 941-948
57. Tanelian DL, Barry MA, Johnston SA, Le T, Smith GM. Semaphorin III can repulse and inhibit adult sensory afferents in vivo. Nat Med 1997; 3: 1398-1401
58. Kawasaki T, Bekku Y, Suto F, et al. Semaphorin III can repulse and inhibit adult sensory afferents in vivo. Development 2002; 129: 671-680
59. Tago H, Kimura H, Maeda T. Visualization of detailed acetylcholinesterase fiber and neuron staining in rat brain by a sensitive histochemical procedure. J Histochem Cytochem 1986; 34: 1431-1438 (Pubitemid 16005395)
60. Kupershmidt S, Yang T, Anderson ME, et al. Replacement by homologous recombination of the minK gene with lacZ reveals restriction of minK expression to the mouse cardiac conduction system. Circ Res 1999; 84: 146-152 (Pubitemid 29070109)
61. Behar O, Golden JA, Mashimo H, Schoen FJ, Fishman MC. Semaphorin III is needed for normal patterning and growth of nerves, bones and heart. Nature 1996; 383: 525-528
62. Taniguchi M, Yuasa S, Fujisawa H, et al. Disruption of semaphorin III/D gene causes severe abnormality in peripheral nerve projection. Neuron 1997; 19: 519-530 (Pubitemid 27430741)
63. Shusterman V, Usiene I, Harrigal C, et al. Strain-specific patterns of autonomic nervous system activity and heart failure susceptibility in mice. Am J Physiol Heart Circ Physiol 2002; 282: H2076-83.
64. Saba S, London B, Ganz L. Autonomic blockade unmasks maturational differences in rate-dependent atrioventricular nodal conduction and facilitation in the mouse. J Cardiovasc Electrophysiol 2003; 14: 191-195 (Pubitemid 36403557)
65. Gulick J, Subramaniam A, Neumann J, Robbins J. Isolation and characterization of the mouse cardiac myosin heavy chain genes. J Biol Chem 1991; 266: 9180-9185 (Pubitemid 21906635)
66. Wehrens XH, Lehnart SE, Reiken SR, et al. Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. Science 2004; 304: 292-296
67. Kannankeril PJ, Mitchell BM, Goonasekera SA, et al. Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine- induced ventricular tachycardia and cardiomyopathy. Proc Natl Acad Sci U S A 2006; 103: 12179-12184
68. Kuo HC, Cheng CF, Clark RB, et al. A defect in the Kv channelinteracting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia. Cell 2001; 107: 801-813
69. Opthof T, Misier AR, Coronel R, et al. Dispersion of refractoriness in canine ventricular myocardium. Effects of sympathetic stimulation. Circ Res 1991; 68: 1204-1215
70. Priori SG, Corr PB. Mechanisms underlying early and delayed afterdepolarizations induced by catecholamines. Am J Physiol 1990; 258: H1796-805.
71. Brunet S, Aimond F, Li H, et al. Heterogeneous expression of repolarizing, voltage-gated K+ currents in adult mouse ventricles. J Physiol 2004; 559: 103-120 (Pubitemid 39206957)
72. Costantini DL, Arruda EP, Agarwal P, et al. The homeodomain transcription factor Irx5 establishes the mouse cardiac ventricular repolarization gradient. Cell 2005; 123: 347-358 (Pubitemid 41457222)